AAAAAA

   
Results: 1-14 |
Results: 14
ORAL GANCICLOVIR DOSING IN TRANSPLANT RECIPIENTS AND DIALYSIS PATIENTS BASED ON RENAL-FUNCTION
Authors: PESCOVITZ MD PRUETT TL GONWA T BROOK B MCGORY R WICKER K GRIFFY K ROBINSON CA JUNG D
Citation: Md. Pescovitz et al., ORAL GANCICLOVIR DOSING IN TRANSPLANT RECIPIENTS AND DIALYSIS PATIENTS BASED ON RENAL-FUNCTION, Transplantation, 66(8), 1998, pp. 1104-1107
MYCOPHENOLATE MOFETIL FOR THE TREATMENT OF A FIRST ACUTE RENAL-ALLOGRAFT REJECTION (VOL 65, PG 235, 1998)
Authors: PESCOVITZ MD CONTI D GREENSTEIN SM INOKUCHI S ROSENTHAL J COHEN D STILLER C PIRSCH J TOMLANOVICH S CHO S DEIERHOI M FERGUSON R GONWA T HODGE E KEOWN PA RAMOS E NAVARRO MT
Citation: Md. Pescovitz et al., MYCOPHENOLATE MOFETIL FOR THE TREATMENT OF A FIRST ACUTE RENAL-ALLOGRAFT REJECTION (VOL 65, PG 235, 1998), Transplantation, 65(7), 1998, pp. 1-1
MYCOPHENOLATE MOFETIL FOR THE TREATMENT OF A FIRST ACUTE RENAL-ALLOGRAFT REJECTION
Authors: PESCOVITZ MD CONTI D GREENSTEIN SM INOKUCHI S ROSENTHAL J COHEN D STILLER C PIRSCH J TOMLANOVICH S CHO S DEIERHOI M FERGUSON R GONWA T HODGE E KEOWN PA RAMOS E NAVARRO MT
Citation: Md. Pescovitz et al., MYCOPHENOLATE MOFETIL FOR THE TREATMENT OF A FIRST ACUTE RENAL-ALLOGRAFT REJECTION, Transplantation, 65(2), 1998, pp. 235-241
DETECTION OF CLINICALLY RELEVANT ANTIBODIES PRETRANSPLANT AND POSTTRANSPLANT WITH PRA-STAT
Authors: NEYLAN J DESMET W STIJLEMANS B BRINKER K GONWA T MORAN J SEGERS A
Citation: J. Neylan et al., DETECTION OF CLINICALLY RELEVANT ANTIBODIES PRETRANSPLANT AND POSTTRANSPLANT WITH PRA-STAT, Transplantation proceedings, 29(1-2), 1997, pp. 330-332
RESCUE THERAPY WITH MYCOPHENOLATE MOFETIL
Authors: CONTI D BAKER J WYNN J DEIERHOI M STUART F WOODLE E FERGUSON R GONWA T PESCOVITZ M STILLER C MENDEZ R ROSENTHAL J PIRSCH J COHEN D CERILLI J BARKER C KAUFFMAN R LINNA J MONROE S NAVARRO M DUNN J INOKUCHI S TOMLANOVICH S WILBURN R LIGHT J TOMLANOVICH SJ
Citation: D. Conti et al., RESCUE THERAPY WITH MYCOPHENOLATE MOFETIL, Clinical transplantation, 10(1), 1996, pp. 131-135
MYCOPHENOLATE MOFETIL FOR THE TREATMENT OF REFRACTORY, ACUTE, CELLULAR RENAL-TRANSPLANT REJECTION
Authors: DANOVITCH G DEIERHOI M FERGUSON R LINNA J MONROE S TOMLANOVICH S CONTI D BAKER J WYNN J STUART F WOODLE E GONWA T PESCOVITZ M STILLER C MENDEZ R ROSENTHAL J PIRSCH J COHEN D CERILLI J BARKER C KAUFFMAN R NAVARRO M DUNN J INOKUCHI S WILBURN R LIGHT J
Citation: G. Danovitch et al., MYCOPHENOLATE MOFETIL FOR THE TREATMENT OF REFRACTORY, ACUTE, CELLULAR RENAL-TRANSPLANT REJECTION, Transplantation, 61(5), 1996, pp. 722-729
HLA COMPATIBILITY AND LIVER-TRANSPLANT OUTCOME - IMPROVED PATIENT SURVIVAL BY HLA AND CROSS-MATCHING
Authors: NIKAEIN A BACKMAN L JENNINGS L LEVY M GOLDSTEIN R GONWA T STONE M KLINTMALM G
Citation: A. Nikaein et al., HLA COMPATIBILITY AND LIVER-TRANSPLANT OUTCOME - IMPROVED PATIENT SURVIVAL BY HLA AND CROSS-MATCHING, Transplantation proceedings, 27(1), 1995, pp. 1186-1188
SURVIVAL OF HEMODIALYSIS-PATIENTS IN THE UNITED-STATES IS IMPROVED WITH A GREATER QUANTITY OF DIALYSIS
Authors: PARKER TF HUSNI L HUANG W LEW N LOWRIE EG HULL A PRATI R LONG D RINNER S WHITE M STEPHENS M EMMETT M VERGNE P SILVERSTEIN R LERMAN M NESSER D VELEZ R BRINKER K FENVES A WALL B GONWA T HUNT J ROJAS G MAI M MELTON L KUNAU R HOOTKINS R MCDONALD L SCHWARTZ J
Citation: Tf. Parker et al., SURVIVAL OF HEMODIALYSIS-PATIENTS IN THE UNITED-STATES IS IMPROVED WITH A GREATER QUANTITY OF DIALYSIS, American journal of kidney diseases, 23(5), 1994, pp. 670-680
CHRONIC NEPHROTOXICITY OF FK-506 AFTER LIVER-TRANSPLANTATION
Authors: BACKMAN L NICAR M LEVY M DISTANT D EISENSTEIN C RENARD T GOLDSTEIN R HUSBERG B GONWA T KLINTMALM G
Citation: L. Backman et al., CHRONIC NEPHROTOXICITY OF FK-506 AFTER LIVER-TRANSPLANTATION, Transplantation proceedings, 26(3), 1994, pp. 1803-1803
WHOLE-BLOOD AND PLASMA-LEVELS OF FK-506 AFTER LIVER-TRANSPLANTATION -CORRELATION WITH TOXICITY
Authors: BACKMAN L NICAR M LEVY M DISTANT D EISENSTEIN C RENARD T GOLDSTEIN R HUSBERG B GONWA T KLINTMALM G
Citation: L. Backman et al., WHOLE-BLOOD AND PLASMA-LEVELS OF FK-506 AFTER LIVER-TRANSPLANTATION -CORRELATION WITH TOXICITY, Transplantation proceedings, 26(3), 1994, pp. 1804-1804
HLA COMPATIBILITY AND LIVER-TRANSPLANT OUTCOME - IMPROVED PATIENT SURVIVAL BY HLA AND CROSS-MATCHING
Authors: NIKAEIN A BACKMAN L JENNINGS L LEVY MF GOLDSTEIN R GONWA T STONE MJ KLINTMALM G
Citation: A. Nikaein et al., HLA COMPATIBILITY AND LIVER-TRANSPLANT OUTCOME - IMPROVED PATIENT SURVIVAL BY HLA AND CROSS-MATCHING, Transplantation, 58(7), 1994, pp. 786-792
THE EFFECT OF VERAPAMIL CONTAINING COLD FLUSH SOLUTION ON THE OUTCOMEOF TRANSPLANTED LIVERS
Authors: DISTANT D WALLACE J BACKMAN L EISENSTEIN C RENARD T LEVY M GOLDSTEIN R HUSBERG B GONWA T KLINTMALM G
Citation: D. Distant et al., THE EFFECT OF VERAPAMIL CONTAINING COLD FLUSH SOLUTION ON THE OUTCOMEOF TRANSPLANTED LIVERS, Hepatology, 18(3), 1993, pp. 730-730
HYPERLIPIDEMIA IN LIVER-TRANSPLANT PATIENTS - PERSISTENCE WITH LONG-TERM FOLLOW-UP
Authors: CRIPPIN JS FOSTER BL CARLEN SL JENNINGS L GONWA T GOLDSTEIN R LEVY M HUSBERG B KLINTMALM G
Citation: Js. Crippin et al., HYPERLIPIDEMIA IN LIVER-TRANSPLANT PATIENTS - PERSISTENCE WITH LONG-TERM FOLLOW-UP, Hepatology, 18(3), 1993, pp. 748-748
IS LIVER-TRANSPLANTATION INDICATED FOR CHOLANGIOCARCINOMA
Authors: GOLDSTEIN RM STONE M TILLERY GW SENZER N LEVY M HUSBERG BS GONWA T KLINTMALM G
Citation: Rm. Goldstein et al., IS LIVER-TRANSPLANTATION INDICATED FOR CHOLANGIOCARCINOMA, The American journal of surgery, 166(6), 1993, pp. 768-772
Risultati: 1-14 |